Team:TU-Eindhoven/Thoughts

From 2012.igem.org

(Difference between revisions)
Line 3: Line 3:
<h3>Issues concerning Material Transfer Agreement</h3>
<h3>Issues concerning Material Transfer Agreement</h3>
-
We obtained the plasmids for the <span class= "green">GECO proteins</span><a href="#ref_zhao" name="text_zhao"><sup>[1]</sup></a></html> via <span class= "green"> Addgene </span>. Addgene is a non-profit organization which is dedicated to providing the scientific community with access to plasmid research tools. The nominal fee for ordering plasmids is used to cover operating costs and improve the repository. There is no fee for depositing plasmids. All requests through Addgene require a <span class= "green">Material Transfer Agreement (MTA)</span>, covered under the Uniform Biological Material Transfer Agreement (UBMTA). By signing this MTA, we were not directly able to distribute our GECO-BioBricks to the Registry.  
+
We obtained the plasmids for the <span class= "green">GECO proteins</span><html><a href="#ref_zhao" name="text_zhao"><sup>[1]</sup></a></html> via <span class= "green"> Addgene </span>. Addgene is a non-profit organization which is dedicated to providing the scientific community with access to plasmid research tools. The nominal fee for ordering plasmids is used to cover operating costs and improve the repository. There is no fee for depositing plasmids. All requests through Addgene require a <span class= "green">Material Transfer Agreement (MTA)</span>, covered under the Uniform Biological Material Transfer Agreement (UBMTA). By signing this MTA, we were not directly able to distribute our GECO-BioBricks to the Registry.  
The MTA only allows <span class= "green">distribution</span> of modified plasmids to <span class= "green">nonprofit organizations </span> for research and teaching purposes only. This distribution to a third party will require a new MTA. However, both the <span class= "green">Registry</span> as well as <span class= "green"> iGEM do not make use of MTAs </span>. Once we found out about this dilemma, we feared we would not be able to send in our GECO-BioBricks to the Registry.  
The MTA only allows <span class= "green">distribution</span> of modified plasmids to <span class= "green">nonprofit organizations </span> for research and teaching purposes only. This distribution to a third party will require a new MTA. However, both the <span class= "green">Registry</span> as well as <span class= "green"> iGEM do not make use of MTAs </span>. Once we found out about this dilemma, we feared we would not be able to send in our GECO-BioBricks to the Registry.  

Revision as of 20:38, 25 September 2012